Quanterix Corporation (QTRX)
USD 6.21
(-7.59%)
USD 6.21
(-7.59%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -38.08 Million USD | 11.07% |
| 2022 | -65.73 Million USD | 26.59% |
| 2021 | -53.23 Million USD | -85.49% |
| 2020 | -27.27 Million USD | 24.1% |
| 2019 | -38.59 Million USD | -33.83% |
| 2018 | -30.19 Million USD | -19.27% |
| 2017 | -25.58 Million USD | -21.63% |
| 2016 | -21.43 Million USD | -48.02% |
| 2015 | -14.47 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -11.14 Million USD | 14.27% |
| 2024 Q1 | -11.96 Million USD | -35.56% |
| 2023 Q1 | -9.48 Million USD | -140.58% |
| 2023 Q2 | -9.56 Million USD | -0.79% |
| 2023 FY | - USD | 11.07% |
| 2023 Q3 | -12.82 Million USD | -34.18% |
| 2023 Q4 | -12.29 Million USD | 4.19% |
| 2022 Q2 | -23.52 Million USD | -39.8% |
| 2022 Q3 | 6.69 Million USD | 128.45% |
| 2022 FY | - USD | 26.59% |
| 2022 Q1 | -16.82 Million USD | 15.42% |
| 2022 Q4 | -3.94 Million USD | -158.91% |
| 2021 Q4 | -19.89 Million USD | -38.98% |
| 2021 Q1 | -8.63 Million USD | 13.04% |
| 2021 Q2 | -12.47 Million USD | -44.42% |
| 2021 FY | - USD | -85.49% |
| 2021 Q3 | -14.31 Million USD | -14.76% |
| 2020 Q4 | -9.93 Million USD | -536.04% |
| 2020 FY | - USD | 24.1% |
| 2020 Q3 | 2.27 Million USD | 118.67% |
| 2020 Q2 | -12.2 Million USD | -2.57% |
| 2020 Q1 | -11.89 Million USD | -4.83% |
| 2019 FY | - USD | -33.83% |
| 2019 Q3 | -10.27 Million USD | -2.38% |
| 2019 Q2 | -10.03 Million USD | -11.6% |
| 2019 Q4 | -11.34 Million USD | -10.41% |
| 2019 Q1 | -8.99 Million USD | -1.43% |
| 2018 Q3 | -7.68 Million USD | -9.47% |
| 2018 Q4 | -8.86 Million USD | -15.36% |
| 2018 FY | - USD | -19.27% |
| 2018 Q1 | -7.17 Million USD | -0.18% |
| 2018 Q2 | -7.02 Million USD | 2.17% |
| 2017 Q4 | -7.16 Million USD | -14.6% |
| 2017 Q1 | -6.03 Million USD | 12.77% |
| 2017 Q2 | -6.28 Million USD | -4.13% |
| 2017 FY | - USD | -21.63% |
| 2017 Q3 | -6.25 Million USD | 0.46% |
| 2016 Q3 | -5.04 Million USD | 5.17% |
| 2016 Q2 | -5.32 Million USD | -26.61% |
| 2016 Q1 | -4.2 Million USD | 0.0% |
| 2016 FY | - USD | -48.02% |
| 2016 Q4 | -6.91 Million USD | -37.07% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -182.405% |
| Cerus Corporation | -26.53 Million USD | -43.533% |
| OrthoPediatrics Corp. | -8.38 Million USD | -354.457% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -262.933% |
| Talis Biomedical Corporation | -66.04 Million USD | 42.33% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -128.414% |
| Inogen, Inc. | -45.67 Million USD | 16.618% |
| Spectral AI, Inc. | -12.26 Million USD | -210.618% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 20.139% |
| CVRx, Inc. | -38.73 Million USD | 1.66% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -979.592% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -214.595% |
| Orthofix Medical Inc. | -86.98 Million USD | 56.213% |
| Venus Concept Inc. | -26.11 Million USD | -45.858% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 23.474% |
| Bioventus Inc. | -23.07 Million USD | -65.098% |
| BrainsWay Ltd. | -2.31 Million USD | -1548.118% |
| Envoy Medical, Inc. | -18.23 Million USD | -108.839% |
| electroCore, Inc. | -17.76 Million USD | -114.459% |
| IceCure Medical Ltd | -15.25 Million USD | -149.708% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 23.443% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -125.965% |
| MaxCyte, Inc. | -44.12 Million USD | 13.687% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -223.988% |
| Nexalin Technology, Inc. | -5.69 Million USD | -569.145% |
| PAVmed Inc | -75.74 Million USD | 49.714% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 29.149% |
| RxSight, Inc. | -41.03 Million USD | 7.186% |
| Sight Sciences, Inc. | -49.41 Million USD | 22.922% |
| SI-BONE, Inc. | -34.44 Million USD | -10.573% |
| TELA Bio, Inc. | -40.63 Million USD | 6.263% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 34.667% |
| Treace Medical Concepts, Inc. | -39 Million USD | 2.358% |
| LivaNova PLC | 39.01 Million USD | 197.621% |
| 908 Devices Inc. | -34.02 Million USD | -11.941% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 65.56% |
| Nemaura Medical Inc. | -7.28 Million USD | -422.68% |
| NeuroPace, Inc. | -22.83 Million USD | -66.804% |
| LENSAR, Inc. | -8.71 Million USD | -337.09% |
| Apyx Medical Corporation | -18.11 Million USD | -110.292% |
| Cutera, Inc. | -136.56 Million USD | 72.109% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1026.864% |
| BioSig Technologies, Inc. | -28.15 Million USD | -35.299% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1613.831% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -81.466% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 109.93% |
| Axonics, Inc. | 7.77 Million USD | 589.878% |
| Outset Medical, Inc. | -153.78 Million USD | 75.234% |
| IRIDEX Corporation | -7.44 Million USD | -411.386% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 61.172% |
| IRadimed Corporation | 20.8 Million USD | 283.11% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -372.439% |
| INVO Bioscience, Inc. | -6.88 Million USD | -453.603% |
| Telesis Bio, Inc. | -40.49 Million USD | 5.939% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 203.847% |
| Varex Imaging Corporation | 67.2 Million USD | 156.679% |
| Quipt Home Medical Corp. | 44.07 Million USD | 186.424% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -250.396% |
| Pulmonx Corporation | -55.09 Million USD | 30.865% |
| Dynatronics Corporation | -976 Thousand USD | -3802.427% |
| Modular Medical, Inc. | -17.1 Million USD | -122.698% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -162.948% |
| Semler Scientific, Inc. | 23.58 Million USD | 261.465% |
| InMode Ltd. | 196.28 Million USD | 119.405% |
| Bruker Corporation | 599 Million USD | 106.359% |
| Cytosorbents Corporation | -28.81 Million USD | -32.2% |
| DexCom, Inc. | 916.7 Million USD | 104.155% |
| Align Technology, Inc. | 799.03 Million USD | 104.767% |
| Viveve Medical, Inc. | -20.61 Million USD | -84.741% |
| ZimVie Inc. | 91.07 Million USD | 141.821% |
| Movano Inc. | -29.12 Million USD | -30.774% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -764.066% |
| Nexalin Technology, Inc. | -5.69 Million USD | -569.145% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -979.592% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 80.433% |
| Profound Medical Corp. | -27.12 Million USD | -40.425% |
| Insulet Corporation | 323.6 Million USD | 111.77% |
| enVVeno Medical Corporation | -25.01 Million USD | -52.242% |
| Surmodics, Inc. | 1.18 Million USD | 3306.061% |
| iCAD, Inc. | -6.56 Million USD | -480.168% |
| Nuwellis, Inc. | -16.35 Million USD | -132.869% |
| Biotricity, Inc. | -8.82 Million USD | -331.432% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 60.678% |
| Aethlon Medical, Inc. | -11.84 Million USD | -221.442% |
| InspireMD, Inc. | -20.91 Million USD | -82.143% |
| PAVmed Inc. | -75.74 Million USD | 49.714% |
| BIOLASE, Inc. | -15.13 Million USD | -151.589% |
| Beyond Air, Inc. | -59.03 Million USD | 35.478% |
| FONAR Corporation | 28.25 Million USD | 234.817% |
| AxoGen, Inc. | -13.32 Million USD | -185.774% |
| Vivani Medical, Inc. | -26.6 Million USD | -43.145% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 255.201% |
| Inari Medical, Inc. | 7.11 Million USD | 635.47% |
| UFP Technologies, Inc. | 72.74 Million USD | 152.36% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1024.938% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -518.714% |
| Tenon Medical, Inc. | -15.52 Million USD | -145.286% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -149.496% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 8.168% |
| AdaptHealth Corp. | -171.09 Million USD | 77.738% |
| Sintx Technologies, Inc. | -6.6 Million USD | -477.091% |
| NanoVibronix, Inc. | -3.43 Million USD | -1008.821% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -250.396% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 127060.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 86.264% |
| TransMedics Group, Inc. | -7.6 Million USD | -400.96% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -74.997% |
| NeuroMetrix, Inc. | -7.09 Million USD | -436.768% |
| Hyperfine, Inc. | -47.06 Million USD | 19.067% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 34.677% |
| Biomerica, Inc. | -5.99 Million USD | -535.541% |
| Bone Biologics Corporation | 479.57 Thousand USD | 8042.082% |
| AVITA Medical, Inc. | -39.56 Million USD | 3.74% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -315.222% |
| Silk Road Medical, Inc | -45.08 Million USD | 15.51% |